Humanized anti-ghrelin antibodies
US7901679B2 · kind B2 · utility
4Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2007 |
| Grant date | Mar 8, 2011 |
| Priority date | — |
| Expiry date | Dec 21, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are humanized monoclonal antibodies, and antigen-binding portions thereof, which bind acylated and unacylated human ghrelin. Such antibodies are useful for neutralizing ghrelin activity and treating disorders in which ghrelin activity is detrimental, including obesity and related disorders, and various cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.